CaMaPi for Adolescents/Young People With a History of Self-harm and Suicidal Ideation in Jos, Nigeria

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-01

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Suicide and self-harm are global disease burden that contributes significantly to years of lost life and mortality.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Suicide Ideation Intervention in Nigeria

NCT05103540

Suicide

NOT_YET_RECRUITING NA

Self-harming Behaviors Study of Adolescents in a Juvenile Detention House

NCT01130441

Adolescent Behavior Harm Reduction

COMPLETED

Developing and Feasibility Testing of a Brief Contact Intervention to Reduce Self-harm Repetition Through Co-design.

NCT05530018

Suicide and Self-harm

COMPLETED NA

Brief Admission for Adolescents Who Self-harm

NCT04962373

Self-Harm, Deliberate Suicide, Attempted Suicidal +1 more

COMPLETED

Advancing Suicide Intervention Strategies for Teens During High Risk Periods

NCT05078970

Suicide Attempts Suicidal Ideation Suicide and Self-harm +1 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Self-harm and suicidal ideation represent a significant global public health concern (Knipe et al., 2022), affecting about 14.6 million people yearly (Nichols et al., 2021). Globally, over 700 000 people die by suicide annually (World Health Organization -- WHO, 2023).

Suicide is the fourth leading cause of death among 15-29-year-olds, and 77% of global suicides occur in low- and middle-income countries, including Nigeria (WHO, 2023). The psychological impact of suicidal ideation includes continuing high tendencies of self-harm (Jidong et al., 2024).

Despite the increasing rates of suicide and self-harm in Nigeria, this topic is understudied, with no culturally appropriate or sustainable psychological interventions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Self-harm Suicidal Ideation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CaMaPi

Group Type EXPERIMENTAL

CaMaPi

Intervention Type BEHAVIORAL

CaMaPi is a manually assisted brief psychological intervention that is based on the principles of Cognitive Behaviour Therapy (CBT). The intervention includes psycho-education and a comprehensive cognitive behavioural assessment of the suicidal ideation and self-harm attempt using virtual stories of four young people to be delivered in 8-10 sessions for over three months

TAU

Group Type ACTIVE_COMPARATOR

TAU

Intervention Type OTHER

Treatment as Usual (TAU) is routine care, such as diagnosis, assessment, psychotherapy, monitoring and any form of intervention (e.g., medication prescription) available at the collaborating service.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CaMaPi

CaMaPi is a manually assisted brief psychological intervention that is based on the principles of Cognitive Behaviour Therapy (CBT). The intervention includes psycho-education and a comprehensive cognitive behavioural assessment of the suicidal ideation and self-harm attempt using virtual stories of four young people to be delivered in 8-10 sessions for over three months

Intervention Type BEHAVIORAL

TAU

Treatment as Usual (TAU) is routine care, such as diagnosis, assessment, psychotherapy, monitoring and any form of intervention (e.g., medication prescription) available at the collaborating service.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 16-24 years presenting to the participating services, and emergency departments or admitted after an episode of self-harm to the participating hospitals or self-referrals.
* Participants will have to be living within the catchment area of the participating practices, services and hospitals.
* Not needing inpatient psychiatric treatment.

Exclusion Criteria

* Severe mental illness (such as Psychotic disorder).
* Conditions limiting engagement with assessment/intervention.
* Temporary resident unlikely to be available for follow up.

Minimum Eligible Age

16 Years

Maximum Eligible Age

24 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes